X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - NLM.NIH.GOV - DailyMed Drug Label Updates - 23/Sep 04:00

OCREVUS ZUNOVO (ocrelizumab and hyaluronidase) injection, solution [Genentech, Inc.]

Updated Date: Mon, 23 Sep 2024 00:00:00 EDT

Articles similaires

Sorry! Image not available at this time

OCREVUS ZUNOVO (ocrelizumab and hyaluronidase) injection, solution [Genentech, Inc.]

nlm.nih.gov - 27/Sep 04:00

Updated Date: Fri, 27 Sep 2024 00:00:00 EDT

Sorry! Image not available at this time

TECENTRIQ HYBREZA (atezolizumab and hyaluronidase-tqjs) injection [Genentech, Inc.]

nlm.nih.gov - 27/Sep 04:00

Updated Date: Fri, 27 Sep 2024 00:00:00 EDT

Sorry! Image not available at this time

POLIVY (polatuzumab vedotin) injection, powder, lyophilized, for solution [Genentech, Inc.]

nlm.nih.gov - 18/Sep 04:00

Updated Date: Wed, 18 Sep 2024 00:00:00 EDT

Sorry! Image not available at this time

ELAHERE (mirvetuximab soravtansine) injection, solution [ImmunoGen, Inc.]

nlm.nih.gov - 23/Sep 04:00

Updated Date: Mon, 23 Sep 2024 00:00:00 EDT

Sorry! Image not available at this time

BIVALIRUDIN injection, solution [MAIA Pharmaceuticals, Inc.]

nlm.nih.gov - 23/Sep 04:00

Updated Date: Mon, 23 Sep 2024 00:00:00 EDT

Sorry! Image not available at this time

DEXDOMITOR (dexmedetomidine hydrochloride) injection, solution [Zoetis Inc.]

nlm.nih.gov - 23/Sep 04:00

Updated Date: Mon, 23 Sep 2024 00:00:00 EDT

Sorry! Image not available at this time

LIDOCAINE HYDROCHLORIDE (lidocaine hydrochloride) injection, solution [Camber Pharmaceuticals, Inc.]

nlm.nih.gov - 23/Sep 04:00

Updated Date: Mon, 23 Sep 2024 00:00:00 EDT

Sorry! Image not available at this time

FDA Approves Ocrevus Zunovo (ocrelizumab & hyaluronidase-ocsq) Twice-A-Year Subcutaneous Injection for People With Relapsing and Progressive Multiple Sclerosis

drugs.com - 17/Sep 05:09

South San Francisco, CA -- September 13, 2024 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the United...

Sorry! Image not available at this time

PRECEDEX (dexmedetomidine hydrochloride) injection, solution PRECEDEX (dexmedetomidine hydrochloride) injection, solution, concentrate [Hospira, Inc.]

nlm.nih.gov - 23/Sep 04:00

Updated Date: Mon, 23 Sep 2024 00:00:00 EDT

Sorry! Image not available at this time

FDA Approves Injectable Ocrevus Zunovo for Relapsing, Progressive MS

drugs.com - 26/Sep 16:09

THURSDAY, Sept. 26, 2024 -- The U.S. Food and Drug Administration has approved Ocrevus Zunovo (ocrelizumab and hyaluronidase-ocsq) as the first and...

Les derniers communiqués